BRENDAN SHAW: Open Payments
NPI 1770111817 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$439 in 16 payments from 11 companies in 2025. Trend: 2023 $1,230 · 2024 $851 · 2025 $439
Food & beverage: $439
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 5 | $149 |
| Janssen Biotech, Inc. | 2 | $42 |
| Davol Inc. | 1 | $41 |
| AstraZeneca Pharmaceuticals LP | 1 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| ABBVIE INC. | 1 | $28 |
| TerSera Therapeutics LLC | 1 | $27 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| On Target Laboratories, Inc | 1 | $21 |
Products named: KEYTRUDA, RYBREVANT, ARISTA, TAGRISSO, ALUNBRIG, IMBRUVICA, Zoladex, SCEMBLIX.
Industry payments across GA — which companies pay providers there.
